IRWD FY 2020 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$629M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$390M-9.1% YoY

Gross Profit

$386M99.2% margin

Operating Income

$143M36.7% margin

Net Income

$106M27.3% margin

EPS (Diluted)

$0.66

Cash Flow

Operating Cash Flow

$169M

Free Cash Flow

$167M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$559M

Total Liabilities

$497M

Stockholders' Equity

$63M

Cash & Equivalents

$364M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$390M	$428M	-9.1%
Gross Profit	$386M	$293M	+31.9%
Operating Income	$143M	$120M	+19.0%
Net Income	$106M	$22M	+393.7%